Apollo Therapeutics, a biopharmaceutical company focused on translating fundamental medical research into medicines, has raised more than £180 million in Series C financing. The Cambridge firm welcomes multiple new investors, including M&G plc and two of the largest US public pension plans, along with existing investor Rock Springs Capital. Patient Square Capital led the round. … Continue reading £180m+ funding medicine for Apollo Therapeutics